Literature DB >> 16494256

Longitudinal studies of outcome and recovery in schizophrenia and early intervention: can they make a difference?

Martin Harrow, Thomas H Jobe.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16494256     DOI: 10.1177/070674370505001401

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  6 in total

Review 1.  Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism.

Authors:  J D Ragland; J Yoon; M J Minzenberg; C S Carter
Journal:  Int Rev Psychiatry       Date:  2007-08

Review 2.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

3.  Remission and recovery during the first outpatient year of the early course of schizophrenia.

Authors:  Joseph Ventura; Kenneth L Subotnik; Lisa H Guzik; Gerhard S Hellemann; Michael J Gitlin; Rachel C Wood; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2011-07-18       Impact factor: 4.939

4.  A word is worth a thousand pictures: A 20-year comparative analysis of aberrant abstraction in schizophrenia, affective psychosis, and non-psychotic depression.

Authors:  Cherise Rosen; Martin Harrow; Liping Tong; Thomas H Jobe; Helen Harrow
Journal:  Schizophr Res       Date:  2021-09-22       Impact factor: 4.939

5.  'An experience of meaning': A 20-year prospective analysis of delusional realities in schizophrenia and affective psychoses.

Authors:  Cherise Rosen; Martin Harrow; Clara Humpston; Liping Tong; Thomas H Jobe; Helen Harrow
Journal:  Front Psychiatry       Date:  2022-08-04       Impact factor: 5.435

6.  The abilities of improved schizophrenia patients to work and live independently in the community: a 10-year long-term outcome study from Mumbai, India.

Authors:  Amresh Kumar Srivastava; Larry Stitt; Meghana Thakar; Nilesh Shah; Gurusamy Chinnasamy
Journal:  Ann Gen Psychiatry       Date:  2009-10-13       Impact factor: 3.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.